Benefits
Antioxidant Activity
EGCG is one of the most potent natural antioxidants — neutralizes reactive oxygen species directly and supports endogenous antioxidant systems (Nrf2 pathway). In vitro activity exceptional; clinical translation more modest.
Weight Management Modest Effects
Hursel 2011 and Phung 2010 meta-analyses show EGCG (especially with caffeine) modestly increases energy expenditure (~4-5% increase) and fat oxidation — translating to modest weight loss (~1-2 kg) over 12 weeks. Effect small; lifestyle intervention foundational.
Cardiovascular Risk Reduction
Green tea consumption (especially Asian populations) associated with reduced CV mortality in observational studies. EGCG may reduce LDL oxidation, improve endothelial function. RCT evidence less robust than observational.
Cancer Prevention Research
Extensive in vitro and animal evidence for cancer prevention via multiple mechanisms (apoptosis induction, angiogenesis inhibition, DNA methylation). Human clinical trials more modest. Not established cancer therapy.
Neuroprotection Research
EGCG crosses blood-brain barrier and has neuroprotective effects in animal models of Alzheimer's, Parkinson's. Human translation limited; popular component of nootropic stacks.
Mechanism of action
Direct Antioxidant Activity
EGCG's gallate group makes it one of the most potent direct antioxidants in nature — directly scavenges hydroxyl radicals, peroxyl radicals, superoxide. Particularly effective at neutralizing peroxynitrite.
Catechol-O-Methyltransferase (COMT) Inhibition
EGCG inhibits COMT — the enzyme that degrades catecholamines and EGCG itself. Slows norepinephrine breakdown, prolonging thermogenic effects (basis for weight management mechanism).
Multiple Cellular Targets
EGCG modulates: Nrf2 (antioxidant response), NF-κB (inflammation), AMPK (energy sensing), PI3K/Akt (growth signaling), MAPK pathways. Pleiotropic effects basis for diverse health claims.
Pro-Oxidant at High Doses (Hepatotoxicity)
Paradoxically, at high concentrations EGCG can act as PRO-OXIDANT — generating reactive oxygen species. May explain hepatotoxicity at supplemental megadoses, particularly in fasted state when liver concentrations peak.
Clinical trials
Meta-analysis of green tea catechins (with and without caffeine) for weight loss across multiple RCTs.
Pooled across weight loss RCTs.
Catechins (with caffeine) modestly reduce weight (~1.3 kg over 12 weeks), waist circumference, BMI vs placebo. Effect smaller without caffeine. Catechins alone less effective than combination with caffeine.
EFSA 2018 scientific opinion on safety of green tea catechins, particularly supplemental EGCG hepatotoxicity.
Safety assessment.
Supplemental EGCG ≥800 mg/day associated with hepatotoxicity cases (elevated liver enzymes, hepatitis, rare acute liver failure); risk increased when taken FASTED. EFSA established 800 mg/day as safety limit for supplemental EGCG. Tea consumption itself generally safe due to lower bioavailability.
About this ingredient
EGCG ((-)-epigallocatechin-3-gallate) is the most abundant catechin in GREEN TEA (Camellia sinensis) — accounting for 50-80% of total catechins. Most clinically-studied of the green tea polyphenols. Distinguished from caffeine by lacking stimulant effects directly; from other catechins by greater abundance and potency. STANDALONE EGCG SUPPLEMENTS provide concentrated doses (typically 200-400 mg per capsule) — substantially more concentrated than green tea consumption (~30-100 mg per cup).
CRITICAL SAFETY ISSUE: HEPATOTOXICITY at supplemental megadoses. EFSA 2018 safety assessment concluded that supplemental EGCG ≥800 mg/day, particularly when taken FASTED, has caused hepatotoxicity ranging from elevated liver enzymes to acute liver failure. Multiple case reports including some fatalities. EFSA established 800 mg/day as safety limit for supplemental EGCG. Tea consumption itself remains generally safe (lower bioavailability and accompanying compounds modify hepatotoxic potential).
EVIDENCE-BASED USES: (1) WEIGHT MANAGEMENT — Hursel 2011 modest effect (~1-2 kg over 12 weeks), particularly with caffeine; (2) ANTIOXIDANT support; (3) CARDIOVASCULAR — observational evidence stronger than RCT; (4) CANCER PREVENTION RESEARCH — preclinical strong, clinical limited; (5) NEUROPROTECTION RESEARCH — preclinical, popular nootropic component.
CRITICAL CAUTIONS: (1) HEPATOTOXICITY — most concerning; AVOID megadoses (>800 mg/day); take with food (not fasted) to reduce absorption peak; obtain BASELINE and periodic LFTs with chronic high-dose use; symptoms (nausea, jaundice, fatigue) require immediate cessation and medical evaluation; (2) FASTED DOSING — increases hepatotoxicity risk; ALWAYS take EGCG with food; (3) BORTEZOMIB — EGCG may REDUCE chemotherapy activity; AVOID during bortezomib treatment; consult oncologist before any green tea supplement during chemotherapy; (4) IRON — catechins reduce iron absorption ~50%; separate from iron supplements by 1-2 hours; iron-deficient patients should be cautious; (5) PREGNANCY — green tea consumption generally considered safe in moderation; high-dose EGCG supplements lack pregnancy safety data; AVOID supplementation; (6) HEPATOTOXIC DRUGS — additive liver toxicity; caution with acetaminophen, methotrexate, isoniazid, statins (rare hepatotoxicity); (7) DOSE — 200-400 mg/day general use is reasonable; >800 mg/day exceeds EFSA safety limit; (8) GREEN TEA CONSUMPTION — drinking green tea (3-5 cups/day) is generally safe and provides ~200-500 mg total catechins with much lower hepatotoxicity risk than concentrated supplements; (9) STANDARDIZATION — verify product is standardized for EGCG content; some 'green tea extract' products contain low EGCG; (10) The risk-benefit calculation for EGCG SUPPLEMENTS (vs green tea consumption) tilts unfavorable for many users — modest benefits don't justify hepatotoxicity risk for most adults; PREFER GREEN TEA over isolated EGCG supplements when possible.